1.Changes of von Willebrand factor and vascular-cellular adhesion molecule-1 in patients with unstable angina
Chinese Journal of Pathophysiology 1999;0(09):-
AIM: To explore the changes of von Willebrand factor (vWF) and soluble vascular-cellular adhesion molecule-1 (sVCAM-1), and the correlation of vWF, sVCAM-1 with acute myocardial ischemia. METHODS: By means of enzyme linked immunosorbent assay (ELISA), the changes of vWF and sVCAM-1 were measured in 73 patients with unstable angina (UA) during angina attack and relief period (24 h after attack) as well as in 50 controls. RESULTS: The levels of vWF and sVCAM-1 were significantly higher in UA patients than those in controls (P
2.The state of immunological functions of breast cancer patients and the effects of surgery and radiotherapy
Xinen ZHAN ; Chengyu LUO ; Jun JIANG
Journal of Third Military Medical University 1984;0(02):-
The dynamic changes of the T cell subsets in the peripheral blood and the serum level of immunoglobin and complement C3 were observed in 32 breast cancer patients before and after surgery and after radiotherapy.20 patients with benign breast diseases and 20 normal women were observed likewise.It was found that the Ts cells and serum IgG and IgA were significantly increased and the TH/Ts ratio markedly decreased in the breast cancer group as compared with those of other 2 groups.In the first postoperative week,TH cells and TH/TS ratio were markedly decreased in all cases operated on.One month after operation,all the parameters returned nearly to the normal level in the group with benign breast diseases.In the group without radiotherapy,the proportion of OKT3+ cells in the 3rd postoperative month and OKT4+ cells in the 6th postoperative month exceeded the preoperative level while that of OKT8+ cells decreased.In the first week after radiotherapy,TH cells decreased,Ts cells increased and TH/Ts ratio decreased significantly.Meanwhile serum IgG was elevated.OKT3+ cells markedly increased in the 6th month after radiotherapy and OKT8+ cells decreased 1 year after that.The immunore-active state of breast cancer patients and the effects of therapeutic measures on them were discussed.
3.A qualitative study on pain experience of discharged patients after thoracoscopic lobectomy
Chengyu ZHANG ; Li JIANG ; Junrong DING
Chinese Journal of Practical Nursing 2021;37(5):359-362
Objective:To understand the pain experience of discharged patients after thoracoscopic lobectomy, identify the out-of-hospital pain management needs of patients, and help patients improve the level of out-of-hospital pain management.Methods:The phenomenological method in qualitative research was used in the study, and the Colaizzi 7-step data analysis method was used to analyze the interview data.Results:Six topics were summarized: pain cognition, different pain coping styles, misunderstanding of painkillers, negative emotions, postoperative paresthesia, and lack of professional guidance.Conclusion:Medical staff should strengthen the publicity and education of discharge, pay attention to the follow-up, provide professional guidance for patients outside the hospital, relieve pain and improve the quality of life of patients.
4.Signal intensity ratio and signal-to-noise ratio of breast lesions in 3.0 T MR diffusion weighted imaging with different b values
Min LIU ; Wanhua LIU ; Rui WANG ; Jing JIANG ; Chengyu PENG ; Jie MIN
Chinese Journal of Radiology 2014;48(3):189-192
Objective To investigate the signal intensity ratio and signal-to-noise ratio of breast lesions in 3.0 T MR diffusion weighted imaging with different b values.Methods Ninety seven patients with 106 solid breast lesions (44 malignant,62 benign) confirmed by pathology were retrospectively analyzed.The patients were examined by 3.0 T MR DWI with different b values (b =0,400,800,1 000 s/mm2) before surgery.The signal-to-noise ratio (SNR) and signal intensity ratio (SIR) of benign and malignant lesions were observed and measured under different b values.One-way ANOVA and t test were used to analyze quantitative data.ROC curve was used to analyze the diagnostic efficiency of SIR under different b values.Results Under different b values,class A image was found in 92 cases,class B images was found in 5 cases.While b value were 0,400,800,1 000 s/mm2,SIR of benign lesions were 2.33 ± 1.36,2.25 ± 1.13,2.06 ± 0.84,2.02 ± 0.79 respectively,SIR of malignant lesions were 2.02 ± 0.79,2.27 ± 0.85,2.61±0.78,2.82 ± 1.01 respectively.While b value was 0 or 400 s/mm2,there was no significant differences for SIR between benign and malignant lesions (t value were 1.58,1.26 respectively; P value were 0.12,0.90 respectively),but there were statistically significances between benign and malignant lesions under b value 800 s/mm2 or 1 000 s/mm2 (t value were 3.41,4.29 respectively ;P <0.01).There was no differences in SIR for benign and malignant lesions under different b values respectively (F value is 1.21,2.22 respectively; P >0.05).While b value were 0,400,800,1 000 s/mm2,the diagnostic sensitivity and specificity of SIR for breast benign and malignant lesions were 56.8% (25/44),56.8% (25/44),75.0% (33/44),77.3% (34/44) and 51.6% (32/62),54.8% (34/62),66.1% (41/62),66.1% (41/62) respectively.While b value were 0,400,800,1 000 s/mm2,SNR were 170 ±93,145 ±72,84 ±41,70 ± 39 respectively.Different b values,there was statistically significant difference between groups (F =55.89,P < 0.01) ; and there were significant differences between every two b values (P < 0.05).Conclusion The higher b values (800 s/mm2 and 1 000 s/mm2) are superior to lower b values in the differential diagnosis of benign and malignant breast lesions using 3.0 T MR scanner.
5.Thinking on the cultivation of students' clinical practice ability under the excellent doctor education training program
Chengyu LIU ; Yuansong WANG ; Yunfang LI ; Zhongxin JIANG ; Zhaogang LIU ; Zhen ZHOU
Chinese Journal of Medical Education Research 2017;16(3):303-306
To implement the excellent doctor education training plan and construct the training model of practical ability in clinical education,the researchers analyzed the problems existing in the training of clinical practice ability and put forward a new train of thought,and constructed a training method system of personal experience,reading classics,teacher guidance,simulation training,clinical practice and reflection strengthening.In addition,we also established a safeguard mechanism with the characteristics of the organizational corporation of teaching,the expert-oriented teaching team,team-oriented mentoring,pro-ject-oriented ability training,the diversification of evaluation system,the modernization of teaching platform and the realistic training environment,to train the qualified clinical medical talents.
6.EFFECT OF KONJAC FOOD ON THE BLOOD GLUECOSE LEVEL IN DIADETICS
Chengyu HUANG ; Maoyu ZHANG ; Shusheng PENG ; Junrong HONG ; Xu WANG ; Huijun JIANG ; Fulin ZHANG ; Yunxiang BAI ;
Acta Nutrimenta Sinica 1956;0(04):-
Seventy two diabetic subjects type Ⅱ were given konjac food for 65 days.The data analysed by multiple F-test indicated that the fasting blood glucosc(FBG), 2-h postprandial blood glucose (PBG) at the 30th and 65th day after consuming the food were significantly reduced (P = 0.001, P200mg%) decreased on the average by 51.8 and 84.6 mg% respectively, those with FBG-O 150-200 mg% by 24.1 and 68.7mg%, and those with FBG-0200 mg%).It could be concluded that konjac food was very useful in both prevention and treatment of hyperglycemia.
7.Expression of mechano-growth factor in Escherichia coli and activity analysis.
Bingbing ZHANG ; Peng JIANG ; Chengyu XIAN ; Yuxiao LI ; Dajun LI ; Liling TANG ; Yuanliang WANG
Chinese Journal of Biotechnology 2008;24(7):1180-1185
Mechano-growth factor (MGF) is one of IGF-1 isoforms. MGF is mechanosensitive and has important functions in muscle hypertrophy, regeneration and nerve injury recovery. In this study, MGF cDNA (330 bp) was cloned from stretched osteoblasts by RT-PCR. In order to avoid prolin residue inhibiting enterokinase cleavage, 9bp of MGF cDNA 5' end sequence was truncated by primer, then the obtained truncated MGF (des(1-3)MGF) cDNA (321 bp) was subcloned in pET32a(+) vector to construct a prokaryotic recombination expression plasmid. Trx/des(1-3)MGF fusion protein, existing in forms of solution, was expressed in transformed Escherichia coli strain BL21(DE3) by IPTG induction at 30 degres C. The supernatant of cell lysates was subjected to ion exchange chromatography and Ni2+ metal affinity chromatography, and the fusion protein was obtained with the purity over 95%. After the fusion protein was cleaved by enterokinase, Trx and des(1-3)MGF was isolated by reverse-phase HPLC. Through these procedures, des(1-3) MGF was obtained with the purity of 98%. The protein molecular mass was conformity to the theoretical value by SDS-PAGE and mass spectrometry analysis. The purified des(1-3)MGF was incubated with MC3T3-E1 for cell proliferation and migration assays. The results show that des(1-3)MGF exhibited more facilitative effects on proliferation and migration of MC3T3-E1 than that of des(1-3)IGF-1.
Cloning, Molecular
;
DNA, Complementary
;
genetics
;
Escherichia coli
;
genetics
;
metabolism
;
Humans
;
Insulin-Like Growth Factor I
;
Osteoblasts
;
metabolism
;
Protein Isoforms
;
biosynthesis
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
pharmacology
;
STAT5 Transcription Factor
;
biosynthesis
;
genetics
;
Tumor Suppressor Proteins
;
biosynthesis
;
genetics
8.Operating conditions for the rapid mutation of the oleaginous yeast by atmospheric and room temperature plasmas and the characteristics of the mutants.
Lihua JIN ; Mingyue FANG ; Chong ZHANG ; Peixia JIANG ; Nan GE ; Heping LI ; Xinhui XING ; Chengyu BAO
Chinese Journal of Biotechnology 2011;27(3):461-467
To obtain oleaginous yeast mutants with improved lipid production and growth rates, an atmospheric and room temperature plasma (ARTP) jet was used with a 96-well plate for high throughput screening. Mutants with changes in growth rates and lipid contents were obtained. At a lethality rate of 99%, the positive mutation rate of the yeast cells was 27.2% evaluated by the growth rates of the mutants and the comparison with the wild strain. The fermentation in a medium composed of yeast extract (10 g/L), peptone (10 g/L) and D-glucose (20 g/L) resulted in the lipid yield of the mutant (C4) with 4.07% (W/W) compared with that of the wild strain (1.87%).
Atmosphere
;
Biofuels
;
Culture Media
;
Fermentation
;
Glucose
;
pharmacology
;
Lipids
;
biosynthesis
;
Mutation
;
Peptones
;
pharmacology
;
Temperature
;
Yeasts
;
genetics
;
growth & development
;
metabolism
9.Application of machine learningin predicting the outcomes and complications of radiotherapy
Shuming ZHANG ; Jiaqi LI ; Hao WANG ; Rongtao JIANG ; Jing SUI ; Chengyu SHI ; Ruijie YANG
Chinese Journal of Radiological Medicine and Protection 2018;38(10):792-795
Machine learning has developed rapidly in recent years.Using machine learning to predict the radiotherapy outcomes and complications can more accurately evaluate the patients' conditions and take appropriate treatment measures as soon as possible.The non-dose and dose related factors generated during radiotherapy are filtered and input into the algorithm model,then corresponding prediction result can be obtained.There are many algorithm models to predict survival rate,tumor control rate and radiotherapy complications,and the predicted result are more accurate now.However,the algorithm model also has various problems,and it needs constant exploration and improvement.
10.Reasons, safety and efficacy analysis for conversion of HAART to TAF/FTC/BIC among HIV-infected patients.
Jiang XIAO ; Guiju GAO ; Yi DING ; Jialu LI ; Chengyu GAO ; Qiuhua XU ; Liang WU ; Hongyuan LIANG ; Liang NI ; Fang WANG ; Yujiao DUAN ; Di YANG ; Hongxin ZHAO
Chinese Medical Journal 2023;136(24):2931-2937
BACKGROUND:
This study aimed to determine the reasons for conversion and elucidate the safety and efficacy of transition to tenofovir alafenamide/emtricitabine/bictegravir sodium (TAF/FTC/BIC) in highly active antiretroviral therapy (HAART)-experienced HIV-infected patients in real-world settings.
METHODS:
We conducted a retrospective cohort study. The treatment conversion rationales, safety, and effectiveness in 1684 HIV-infected patients with previous HAART experience who switched to TAF/FTC/BIC were evaluated at Beijing Ditan Hospital from September 2021 to Auguest 2022.
RESULTS:
Regimen simplification (990/1684, 58.79%) was the most common reason for switching, followed by osteoporosis or osteopenia (375/1684, 22.27%), liver dysfunction (231/1684, 13.72%), decline in tenofovir alafenamide/emtricitabine/elvitegravir/cobicistat (TAF/FTC/EVG/c) with food restriction (215/1684, 12.77%), virological failure (116/1684, 6.89%), and renal dysfunction (90/1684, 5.34%). In patients receiving non-nucleotide reverse transcriptase inhibitors (NNRTI)-containing regimens, lipid panel changes 1 year after switching indicated a difference of 3.27 ± 1.10 mmol/L vs . 3.40 ± 1.59 mmol/L in triglyceride ( P = 0.014), 4.82 ± 0.74 mmol/L vs . 4.88 ± 0.72 mmol/L in total cholesterol ( P = 0.038), 3.09 ± 0.70 mmol/L vs . 3.18 ± 0.66 mmol/L in low-density lipoprotein ( P <0.001), and 0.99 ± 0.11 mmol/L vs . 0.95 ± 0.10 mmol/L in high-density lipoprotein ( P <0.001). Conversely, among patients receiving booster-containing regimens, including TAF/FTC/EVG/c and lopinavir/ritonavir (LPV/r), lipid panel changes presented decreased trends. We also observed an improved trend in viral load suppression, and alanine transaminase (ALT), aspartate transaminase (AST), estimated glomerular filtration rate (eGFR), and serum creatinine levels after the transition ( P <0.001).
CONCLUSION
The transition to TAF/FTC/BIC demonstrated good treatment potency. Furthermore, this study elucidates the motivations behind the adoption of TAF/FTC/BIC in real-world scenarios, providing clinical evidence supporting the stable conversion to TAF/FTC/BIC for HAART-experienced patients.
Humans
;
Antiretroviral Therapy, Highly Active/adverse effects*
;
Anti-HIV Agents/adverse effects*
;
HIV Infections/drug therapy*
;
Tenofovir/therapeutic use*
;
Retrospective Studies
;
Emtricitabine/pharmacology*
;
Adenine/therapeutic use*
;
Lipids